Testing by the National Medicines Institute showed that the product does not meet quality requirements: release of mebeverine hydrochloride after 2, 8 and 12 hours was below the lower acceptance limit, which affects the effectiveness of the medicine. Potential effects: reduced effectiveness in treating intestinal complaints and possible worsening of disease symptoms.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Mebelin with the specified GTIN numbers (all batches). Patients should consult a doctor or pharmacist regarding continuation of therapy and possible replacement of the medicine at the pharm...
The Chief Pharmaceutical Inspector withdrew Mebelin from the market throughout the country for all batches, granted the decision immediate enforceability, and had previously sent the product for quali...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related